Gagliardini, Roberta
 Distribuzione geografica
Continente #
EU - Europa 888
NA - Nord America 741
AS - Asia 196
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
AF - Africa 1
Totale 1.834
Nazione #
US - Stati Uniti d'America 739
DE - Germania 211
PL - Polonia 200
SE - Svezia 145
FR - Francia 112
IT - Italia 96
CN - Cina 91
UA - Ucraina 44
IN - India 33
SG - Singapore 33
IE - Irlanda 30
ID - Indonesia 19
GB - Regno Unito 18
FI - Finlandia 16
RU - Federazione Russa 6
TR - Turchia 6
HK - Hong Kong 5
IR - Iran 5
AU - Australia 2
BE - Belgio 2
BR - Brasile 2
CA - Canada 2
CL - Cile 2
DK - Danimarca 2
EU - Europa 2
JP - Giappone 2
AT - Austria 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
MM - Myanmar 1
MT - Malta 1
NL - Olanda 1
TN - Tunisia 1
VN - Vietnam 1
Totale 1.834
Città #
Kraków 199
Chandler 183
Ashburn 51
Jacksonville 51
New York 40
Dublin 30
Redmond 30
San Mateo 29
Milan 24
Ann Arbor 20
Houston 20
Singapore 20
Jakarta 19
Nanjing 18
Boston 17
Dearborn 17
Wilmington 15
Nürnberg 14
Cattolica 13
Lawrence 12
Changsha 11
Lancaster 11
Rome 11
Woodbridge 10
Beijing 9
Nanchang 9
Fairfield 8
Redwood City 7
Izmir 6
Kunming 6
Los Angeles 6
Princeton 6
Pune 6
Seattle 6
Marseille 5
Shenyang 5
Verona 5
Falls Church 4
Hebei 4
Hong Kong 4
Washington 4
Boardman 3
Cambridge 3
Clearwater 3
Hangzhou 3
Jinan 3
Leawood 3
Munich 3
Paris 3
Turin 3
University Park 3
Andover 2
Augusta 2
Bari 2
Bremen 2
Brussels 2
Cupertino 2
Fuzhou 2
Helsinki 2
Henderson 2
Modena 2
Mountain View 2
Norwalk 2
Shanghai 2
Simi Valley 2
São Paulo 2
Tianjin 2
Toronto 2
Amsterdam 1
Ardabil 1
Auburn Hills 1
Bangalore 1
Bologna 1
Chongqing 1
Clifton 1
Downers Grove 1
Edinburgh 1
Guangzhou 1
Hanoi 1
Hefei 1
Il-Madliena 1
Jiaxing 1
Kish 1
London 1
Monmouth Junction 1
Monterotondo 1
Moscow 1
Novokuznetsk 1
Phoenix 1
San Diego 1
San Jose 1
Sassari 1
Sovicille 1
Taizhou 1
Tallinn 1
Thessaloníki 1
Tokyo 1
Torino 1
Tunis 1
Velletri 1
Totale 1.061
Nome #
Pharmacokinetics of etravirine in HIV-infected patients concomitantly treated with rifampin for tuberculosis 173
Prevalence of osteoporosis and predictors of low BMD in a cohort of HIV-1-infected patients in Rome: features of a population at high risk 168
Liver fibrosis is associated with cognitive impairment in HIV-positive patients 162
Switching to lamivudine plus darunavir/r dual therapy in a cohort of treatment-experienced HIV-positive patients: the experience of an Italian centre 157
Safety and therapeutic efficacy of the switch to maraviroc+darunavir/ritonavir in HIV/HCV coinfected patients: initial results from GUSTA study 137
Neuropsychological screening tools in Italian HIV+ patients: a comparison of Montreal Cognitive Assessment (MoCA) and Mini Mental State Examination (MMSE) 128
Ophthalmic artery resistance index IS increased in HIV-Infected patients and is influenced by protease inhibitors exposure 121
Efficacy and safety of treatment simplification to atazanavir/ritonavir + lamivudine in HIV-infected patients with virological suppression: 144 week follow-up of the AtLaS pilot study 104
Virological control and metabolic improvement in HIV-infected, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy 101
Bone mineral density improvement after 48 weeks of switch to maraviroc+darunavir/ritonavir 300/800/100 mg QD, preliminary results of GUSTA study 90
Lipid-lowering effect and changes in estimated cardiovascular risk after switching to a tenofovir-containing regimen for the treatment of HIV-infected patients 88
Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial 84
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy: 48-Week results of a randomized trial 82
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial 60
Liver fibrosis progression and clinical outcomes are intertwined: Role of CD4+ T-cell count and NRTI exposure from a large cohort of HIV/HCVcoinfected patients with detectable HCV-RNA A MASTER cohort study 57
3-Year efficacy and durability of simplification to single tablet regimens: a comparison between co-formulated efavirenz/emtricitabine/tenofovir and rilpivirine/emtricitabine/tenofovir 54
Impact of the M184V Resistance Mutation on Virological Efficacy and Durability of Lamivudine-Based Dual Antiretroviral Regimens as Maintenance Therapy in Individuals With Suppressed HIV-1 RNA: A Cohort Study 53
Two Distinct Hepatitis C Virus Genotype 1a Clades Have Different Geographical Distribution and Association With Natural Resistance to NS3 Protease Inhibitors 35
Totale 1.854
Categoria #
all - tutte 6.572
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.572


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020143 0 0 0 4 17 22 11 16 15 8 38 12
2020/2021103 12 13 1 12 12 7 3 1 19 4 17 2
2021/2022204 4 11 4 17 6 15 4 36 14 29 26 38
2022/2023426 66 69 29 68 28 55 7 50 44 1 8 1
2023/2024205 6 63 4 23 12 50 14 1 0 2 22 8
2024/202538 3 14 21 0 0 0 0 0 0 0 0 0
Totale 1.854